San Diego Business Journal

The California Institute for Regenerative Medicine, the state agency providing money for stem-cell research, said Oct. 28 that it awarded $230 million in grants and loans.

At the same time, agencies in Canada and Great Britain made $43 million in grants.

Four awards have at least one San Diego tie. They break down as follows:

• $20 million will go to scientist Emmanuel Baetge of San Diego-based Novocell. Baetge is working with UC San Francisco researcher Jeffrey Bluestone on a treatment for people with type 1 diabetes. The $20 million will be a loan.

• $19.2 million will go to scientist Mitchel Berger of UC San Francisco, who is working with Webster Cavenee of the Ludwig Institute for Cancer Research as well as Evan Snyder of the Burnham Institute for Medical Research. The group wants to develop a treatment for brain tumors.

• $20 million will go to scientist Dennis Carson of UC San Diego, who is working with Catriona Jamieson of UC San Diego and John Dick of the University Health Network of Toronto. The group is working on drugs to treat leukemia.

• $15.6 million will go to scientist Samuel Pfaff of the Salk Institute for Biological Studies, working with Lawrence Goldstein of UC San Diego and Don Cleveland of the Ludwig Institute for Cancer Research. The researchers are proposing a way to treat Lou Gehrig’s disease, or amyotrophic lateral sclerosis.

The grants are part of the $3 billion in stem cell research money raised and distributed by the state after California voters approved Proposition 71 in 2004.

— Brad Graves